In contrast with these results, when it was tested on patients with metabolic syndrome or prediabetes, a dose of 75 mg/day did not bring significant improvements in the glycemic profile (fasting serum INS, FBS, and HbA1c) [106,107]. This evidence concerns the gene INS and metabolic syndrome.